{"canonical":"https://abierto.us/vendors/perfusion-medical-inc-xedjgxp1k889","key":"XEDJGXP1K889","name":"PERFUSION MEDICAL, INC.","uei":"XEDJGXP1K889","city":"HERNDON","state":"VA","awards":5,"obligated":"5208982.00","notices_won":0,"top_agency_name":"Department of the Air Force","top_naics":"541715","cage":"8MYE9","parent_name":"PERFUSION MEDICAL, INC.","also_known_as":[],"country":"USA","actions":14,"first_action":"2024-02-08","last_action":"2026-04-03","breakdowns":{"naics":[{"key":"541715","name":null,"awards":5,"obligated":"5208982.00"}],"places":[{"key":"VA","name":null,"awards":5,"obligated":"5208982.00"}],"agencies":[{"key":"5700","name":"Department of the Air Force","awards":3,"obligated":"3709209.00"},{"key":"97DH","name":"Defense Health Agency","awards":2,"obligated":"1499773.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":5,"obligated":"5208982.00"}],"award_types":[{"key":"PURCHASE ORDER","name":null,"awards":3,"obligated":"3709209.00"},{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"1499773.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":5,"obligated":"5208982.00"}],"product_service_codes":[{"key":"AC32","name":null,"awards":3,"obligated":"3709209.00"},{"key":"AN12","name":null,"awards":2,"obligated":"1499773.00"}]},"awards_list":[{"award_key":"CONT_AWD_FA864924P0531_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_FA864924P0531_9700_-NONE-_-NONE-/","piid":"FA864924P0531","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"XEDJGXP1K889","recipient_name":"PERFUSION MEDICAL, INC.","recipient_uei":"XEDJGXP1K889","recipient_cage":"8MYE9","recipient_city":"HERNDON","recipient_state":"VA","sub_name":"Department of the Air Force","office_name":"FA8649 USAF SBIR STTR CNTRCTNG AFRL","office_key":"o-FA8649","first_action_date":"2024-06-21","last_action_date":"2025-09-25","actions":5,"obligated":"1799970.00","current_total_value":"1799970.00","potential_total_value":"1799970.00","naics":"541715","psc":"AC32","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":84,"description":"HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_FA864924P0552_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_FA864924P0552_9700_-NONE-_-NONE-/","piid":"FA864924P0552","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"XEDJGXP1K889","recipient_name":"PERFUSION MEDICAL, INC.","recipient_uei":"XEDJGXP1K889","recipient_cage":"8MYE9","recipient_city":"HERNDON","recipient_state":"VA","sub_name":"Department of the Air Force","office_name":"FA8649 USAF SBIR STTR CNTRCTNG AFRL","office_key":"o-FA8649","first_action_date":"2024-02-08","last_action_date":"2025-11-18","actions":3,"obligated":"1799322.00","current_total_value":"1799322.00","potential_total_value":"1799322.00","naics":"541715","psc":"AC32","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":84,"description":"RESEARCH AND DEVELOPMENT OF OPTIMAL DOSING AND FORMULATION OF PM-208 (PEG-20K/8K) FOR AF FIELD USE","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HT942726CE025_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HT942726CE025_9700_-NONE-_-NONE-/","piid":"HT942726CE025","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"XEDJGXP1K889","recipient_name":"PERFUSION MEDICAL, INC.","recipient_uei":"XEDJGXP1K889","recipient_cage":"8MYE9","recipient_city":"HERNDON","recipient_state":"VA","sub_name":"Defense Health Agency","office_name":"DEFENSE HEALTH AGENCY","office_key":"o-HT9427","first_action_date":"2026-04-03","last_action_date":"2026-04-03","actions":1,"obligated":"1499773.00","current_total_value":"1499773.00","potential_total_value":"1499773.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":1,"description":"IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_FA864924P0833_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_FA864924P0833_9700_-NONE-_-NONE-/","piid":"FA864924P0833","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"XEDJGXP1K889","recipient_name":"PERFUSION MEDICAL, INC.","recipient_uei":"XEDJGXP1K889","recipient_cage":"8MYE9","recipient_city":"HERNDON","recipient_state":"VA","sub_name":"Department of the Air Force","office_name":"FA8649 USAF SBIR STTR CNTRCTNG AFRL","office_key":"o-FA8649","first_action_date":"2024-05-13","last_action_date":"2024-05-13","actions":1,"obligated":"109917.00","current_total_value":"109917.00","potential_total_value":"109917.00","naics":"541715","psc":"AC32","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":494,"description":"POLYETHYLENE GLYCOL-20K/8K (PEG-20K/8K): A PATENTED INTRAVENOUS SOLUTION IN UNCONTROLLED HEMORRHAGE","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HT942523C0065_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HT942523C0065_9700_-NONE-_-NONE-/","piid":"HT942523C0065","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"XEDJGXP1K889","recipient_name":"PERFUSION MEDICAL, INC.","recipient_uei":"XEDJGXP1K889","recipient_cage":"8MYE9","recipient_city":"HERNDON","recipient_state":"VA","sub_name":"Defense Health Agency","office_name":"ARMY MED RES ACQ ACTIVITY","office_key":"o-HT9425","first_action_date":"2024-04-26","last_action_date":"2025-07-29","actions":4,"obligated":"0","current_total_value":"2986772.93","potential_total_value":"2986772.93","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":5,"description":"DHA SBIR DIRECT TO PHASE II - II PROPOSAL H2D-0122: \"IND-ENABLING STUDIES OF PM-208: A NOVEL PREHOSPITAL ANTI-SHOCK THERAPEUTIC\"","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":5,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}